Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Subjects Affected by Acanthamoeba Keratitis
Condition:   Acanthamoeba Keratitis Interventions:   Drug: PHMB 0.08%;   Drug: Propamidine 0.1%;   Drug: placebo;   Drug: PHMB 0.02% Sponsor:   SIFI SpA Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2017 Category: Research Source Type: clinical trials